HEADER VIRAL PROTEIN 08-OCT-22 8H39 TITLE STRUCTURE OF ACB2 COMPLEXED WITH C-DI-AMP COMPND MOL_ID: 1; COMPND 2 MOLECULE: P26; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS PHAGE PAP2; SOURCE 3 ORGANISM_TAXID: 270673; SOURCE 4 GENE: ORF26; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, COMPLEX, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Y.FENG,X.L.CAO REVDAT 3 03-APR-24 8H39 1 REMARK REVDAT 2 08-MAR-23 8H39 1 JRNL REVDAT 1 22-FEB-23 8H39 0 JRNL AUTH E.HUITING,X.CAO,J.REN,J.S.ATHUKORALAGE,Z.LUO,S.SILAS,N.AN, JRNL AUTH 2 H.CARION,Y.ZHOU,J.S.FRASER,Y.FENG,J.BONDY-DENOMY JRNL TITL BACTERIOPHAGES INHIBIT AND EVADE CGAS-LIKE IMMUNE FUNCTION JRNL TITL 2 IN BACTERIA. JRNL REF CELL V. 186 864 2023 JRNL REFN ISSN 1097-4172 JRNL PMID 36750095 JRNL DOI 10.1016/J.CELL.2022.12.041 REMARK 2 REMARK 2 RESOLUTION. 2.01 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.01 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 67.58 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 43227 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.230 REMARK 3 FREE R VALUE TEST SET COUNT : 2261 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 67.5800 - 5.0600 0.99 2668 191 0.1972 0.2177 REMARK 3 2 5.0500 - 4.0100 1.00 2633 131 0.1774 0.1988 REMARK 3 3 4.0100 - 3.5100 1.00 2582 152 0.1868 0.2097 REMARK 3 4 3.5000 - 3.1900 1.00 2551 157 0.2049 0.2152 REMARK 3 5 3.1800 - 2.9600 1.00 2580 116 0.2199 0.2425 REMARK 3 6 2.9600 - 2.7800 1.00 2550 153 0.2348 0.2257 REMARK 3 7 2.7800 - 2.6400 1.00 2569 130 0.2278 0.2194 REMARK 3 8 2.6400 - 2.5300 1.00 2547 135 0.2334 0.3044 REMARK 3 9 2.5300 - 2.4300 1.00 2526 148 0.2342 0.2806 REMARK 3 10 2.4300 - 2.3500 1.00 2557 133 0.2409 0.2594 REMARK 3 11 2.3500 - 2.2700 1.00 2539 125 0.2308 0.2663 REMARK 3 12 2.2700 - 2.2100 1.00 2516 138 0.2292 0.2307 REMARK 3 13 2.2100 - 2.1500 1.00 2570 145 0.2237 0.2600 REMARK 3 14 2.1500 - 2.1000 1.00 2512 131 0.2237 0.3045 REMARK 3 15 2.1000 - 2.0500 1.00 2528 128 0.2437 0.3337 REMARK 3 16 2.0500 - 2.0100 1.00 2538 148 0.2746 0.3402 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.260 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.530 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.88 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8H39 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 11-OCT-22. REMARK 100 THE DEPOSITION ID IS D_1300032743. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-AUG-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL02U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 S 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROCESS REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43247 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.010 REMARK 200 RESOLUTION RANGE LOW (A) : 67.580 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 20.00 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 21.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.01 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: ALPHAFOLD2 MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, SODIUM BROMIDE, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 3 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z REMARK 290 6555 -X,-X+Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 4 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 102.04300 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 5 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 5 0.000000 0.000000 -1.000000 102.04300 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 6 0.000000 0.000000 -1.000000 102.04300 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 4 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 5 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 52.07100 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 -90.18962 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 104.14200 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 52.07100 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 -90.18962 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 104.14200 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 232 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 272 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 MET B 1 REMARK 465 ASP B 2 REMARK 465 ASN B 3 REMARK 465 MET C 1 REMARK 465 ASP C 2 REMARK 465 ASN C 3 REMARK 465 MET D 1 REMARK 465 ASP D 2 REMARK 465 MET E 1 REMARK 465 ASP E 2 REMARK 465 MET F 1 REMARK 465 ASP F 2 REMARK 465 ASN F 3 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU B 51 CG CD1 CD2 REMARK 470 LYS C 6 CG CD CE NZ REMARK 470 LYS F 6 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 89 72.96 60.19 REMARK 500 GLN B 89 86.31 58.77 REMARK 500 GLN C 89 75.41 56.26 REMARK 500 ASP C 91 35.33 -95.39 REMARK 500 GLN D 89 75.83 58.85 REMARK 500 ASP D 91 32.12 -97.32 REMARK 500 GLN E 89 80.17 57.96 REMARK 500 GLN F 89 80.39 57.37 REMARK 500 REMARK 500 REMARK: NULL DBREF 8H39 A 1 93 UNP Q6PVL0 Q6PVL0_9CAUD 1 93 DBREF 8H39 B 1 93 UNP Q6PVL0 Q6PVL0_9CAUD 1 93 DBREF 8H39 C 1 93 UNP Q6PVL0 Q6PVL0_9CAUD 1 93 DBREF 8H39 D 1 93 UNP Q6PVL0 Q6PVL0_9CAUD 1 93 DBREF 8H39 E 1 93 UNP Q6PVL0 Q6PVL0_9CAUD 1 93 DBREF 8H39 F 1 93 UNP Q6PVL0 Q6PVL0_9CAUD 1 93 SEQRES 1 A 93 MET ASP ASN GLN HIS LYS LYS ILE LYS GLY TYR ARG ASP SEQRES 2 A 93 LEU SER GLN GLU GLU ILE ASP MET MET ASN ARG VAL LYS SEQRES 3 A 93 GLU LEU GLY SER GLN PHE GLU LYS LEU ILE GLN ASP VAL SEQRES 4 A 93 SER ASP HIS LEU ARG GLY GLN TYR ASN ALA SER LEU HIS SEQRES 5 A 93 ASN ARG ASP GLU ILE THR ARG ILE ALA ASN ALA GLU PRO SEQRES 6 A 93 GLY ARG TRP LEU ALA ILE GLY LYS THR ASP ILE GLN THR SEQRES 7 A 93 GLY MET MET ALA ILE ILE ARG ALA ILE ALA GLN PRO ASP SEQRES 8 A 93 SER PHE SEQRES 1 B 93 MET ASP ASN GLN HIS LYS LYS ILE LYS GLY TYR ARG ASP SEQRES 2 B 93 LEU SER GLN GLU GLU ILE ASP MET MET ASN ARG VAL LYS SEQRES 3 B 93 GLU LEU GLY SER GLN PHE GLU LYS LEU ILE GLN ASP VAL SEQRES 4 B 93 SER ASP HIS LEU ARG GLY GLN TYR ASN ALA SER LEU HIS SEQRES 5 B 93 ASN ARG ASP GLU ILE THR ARG ILE ALA ASN ALA GLU PRO SEQRES 6 B 93 GLY ARG TRP LEU ALA ILE GLY LYS THR ASP ILE GLN THR SEQRES 7 B 93 GLY MET MET ALA ILE ILE ARG ALA ILE ALA GLN PRO ASP SEQRES 8 B 93 SER PHE SEQRES 1 C 93 MET ASP ASN GLN HIS LYS LYS ILE LYS GLY TYR ARG ASP SEQRES 2 C 93 LEU SER GLN GLU GLU ILE ASP MET MET ASN ARG VAL LYS SEQRES 3 C 93 GLU LEU GLY SER GLN PHE GLU LYS LEU ILE GLN ASP VAL SEQRES 4 C 93 SER ASP HIS LEU ARG GLY GLN TYR ASN ALA SER LEU HIS SEQRES 5 C 93 ASN ARG ASP GLU ILE THR ARG ILE ALA ASN ALA GLU PRO SEQRES 6 C 93 GLY ARG TRP LEU ALA ILE GLY LYS THR ASP ILE GLN THR SEQRES 7 C 93 GLY MET MET ALA ILE ILE ARG ALA ILE ALA GLN PRO ASP SEQRES 8 C 93 SER PHE SEQRES 1 D 93 MET ASP ASN GLN HIS LYS LYS ILE LYS GLY TYR ARG ASP SEQRES 2 D 93 LEU SER GLN GLU GLU ILE ASP MET MET ASN ARG VAL LYS SEQRES 3 D 93 GLU LEU GLY SER GLN PHE GLU LYS LEU ILE GLN ASP VAL SEQRES 4 D 93 SER ASP HIS LEU ARG GLY GLN TYR ASN ALA SER LEU HIS SEQRES 5 D 93 ASN ARG ASP GLU ILE THR ARG ILE ALA ASN ALA GLU PRO SEQRES 6 D 93 GLY ARG TRP LEU ALA ILE GLY LYS THR ASP ILE GLN THR SEQRES 7 D 93 GLY MET MET ALA ILE ILE ARG ALA ILE ALA GLN PRO ASP SEQRES 8 D 93 SER PHE SEQRES 1 E 93 MET ASP ASN GLN HIS LYS LYS ILE LYS GLY TYR ARG ASP SEQRES 2 E 93 LEU SER GLN GLU GLU ILE ASP MET MET ASN ARG VAL LYS SEQRES 3 E 93 GLU LEU GLY SER GLN PHE GLU LYS LEU ILE GLN ASP VAL SEQRES 4 E 93 SER ASP HIS LEU ARG GLY GLN TYR ASN ALA SER LEU HIS SEQRES 5 E 93 ASN ARG ASP GLU ILE THR ARG ILE ALA ASN ALA GLU PRO SEQRES 6 E 93 GLY ARG TRP LEU ALA ILE GLY LYS THR ASP ILE GLN THR SEQRES 7 E 93 GLY MET MET ALA ILE ILE ARG ALA ILE ALA GLN PRO ASP SEQRES 8 E 93 SER PHE SEQRES 1 F 93 MET ASP ASN GLN HIS LYS LYS ILE LYS GLY TYR ARG ASP SEQRES 2 F 93 LEU SER GLN GLU GLU ILE ASP MET MET ASN ARG VAL LYS SEQRES 3 F 93 GLU LEU GLY SER GLN PHE GLU LYS LEU ILE GLN ASP VAL SEQRES 4 F 93 SER ASP HIS LEU ARG GLY GLN TYR ASN ALA SER LEU HIS SEQRES 5 F 93 ASN ARG ASP GLU ILE THR ARG ILE ALA ASN ALA GLU PRO SEQRES 6 F 93 GLY ARG TRP LEU ALA ILE GLY LYS THR ASP ILE GLN THR SEQRES 7 F 93 GLY MET MET ALA ILE ILE ARG ALA ILE ALA GLN PRO ASP SEQRES 8 F 93 SER PHE HET 2BA A 101 44 HET EDO A 102 4 HET EDO A 103 4 HET 2BA B 101 44 HET EDO B 102 4 HET EDO C 201 4 HET 2BA D 101 44 HET EDO D 102 4 HET 2BA E 101 44 HET EDO E 102 4 HET EDO F 101 4 HET EDO F 102 4 HETNAM 2BA (2R,3R,3AS,5R,7AR,9R,10R,10AS,12R,14AR)-2,9-BIS(6- HETNAM 2 2BA AMINO-9H-PURIN-9-YL)OCTAHYDRO-2H,7H-DIFURO[3,2-D:3', HETNAM 3 2BA 2'-J][1,3,7,9,2,8 ]TETRAOXADIPHOSPHACYCLODODECINE-3,5, HETNAM 4 2BA 10,12-TETROL 5,12-DIOXIDE HETNAM EDO 1,2-ETHANEDIOL HETSYN 2BA BIS-(3',5')-CYCLIC-DIMERIC-ADENOSINE-MONOPHOSPHATE HETSYN EDO ETHYLENE GLYCOL FORMUL 7 2BA 4(C20 H24 N10 O12 P2) FORMUL 8 EDO 8(C2 H6 O2) FORMUL 19 HOH *286(H2 O) HELIX 1 AA1 ASN A 3 ILE A 8 5 6 HELIX 2 AA2 SER A 15 SER A 50 1 36 HELIX 3 AA3 ASN A 53 GLU A 64 1 12 HELIX 4 AA4 GLU A 64 GLN A 89 1 26 HELIX 5 AA5 GLN B 4 ILE B 8 5 5 HELIX 6 AA6 SER B 15 SER B 50 1 36 HELIX 7 AA7 ASN B 53 GLU B 64 1 12 HELIX 8 AA8 GLU B 64 GLN B 89 1 26 HELIX 9 AA9 SER C 15 SER C 50 1 36 HELIX 10 AB1 ASN C 53 GLU C 64 1 12 HELIX 11 AB2 GLU C 64 GLN C 89 1 26 HELIX 12 AB3 ASN D 3 ILE D 8 5 6 HELIX 13 AB4 SER D 15 LEU D 51 1 37 HELIX 14 AB5 ASN D 53 GLU D 64 1 12 HELIX 15 AB6 GLU D 64 GLN D 89 1 26 HELIX 16 AB7 ASN E 3 LYS E 7 5 5 HELIX 17 AB8 SER E 15 SER E 50 1 36 HELIX 18 AB9 ASN E 53 GLU E 64 1 12 HELIX 19 AC1 GLU E 64 GLN E 89 1 26 HELIX 20 AC2 GLN F 4 ILE F 8 5 5 HELIX 21 AC3 SER F 15 SER F 50 1 36 HELIX 22 AC4 ASN F 53 GLU F 64 1 12 HELIX 23 AC5 GLU F 64 GLN F 89 1 26 CRYST1 104.142 104.142 102.043 90.00 90.00 120.00 P 3 2 1 36 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009602 0.005544 0.000000 0.00000 SCALE2 0.000000 0.011088 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009800 0.00000